David Hartnett is Vice President, Economic Development for the Metro Atlanta Chamber, focused on bioscience & health IT industry development. He has more than 19 years of senior management, Medical Device/Pharmaceutical, and health IT experience with early stage to publicly traded companies. David’s diverse experience has contributed to the success of six premier medical device companies receiving international recognition. He has served as a lead in the management, development and commercialization of over 14 medical devices, ranging in classification. Prior experience includes Managing Partner of Medical Device Marketing®, a privately held consulting and strategic execution company, specializing in medical device commercialization and President and CEO of UnitedPharma®/MacoPharma. Prior to UnitedPharma held the position as President and CEO of SteriFx® Corporation, a specialty chemical company, contracted by U.S. Department of Defense (DARPA division). Prior to SteriFx, he was the executive vice president of the North American headquarters for Given Imaging, Inc. While at Given, Hartnett helped to raise more than $30 million in private equity for corporate infrastructure development and product commercialization prior to the company going public in 2001 ( GIVN - NASDAQ). He has also served in a variety of other key sales and marketing roles for the following companies: Karl Storz Lithotripsy, Genzyme (formerly Deknatel), STERIS (formerly AMSCO) and the XEROX Corporation.

He is currently serves on the board and/or affiliated with the following professional organizations:

• Georgia Bio (GABIO), Board of Directors
• Technology Association of Georgia (TAG), Board of Directors
• MIT Forum, Board of Directors
• Venture Atlanta Coalition, Co-Founder, Board of Directors
• Innovation Crescent Regional Partnership, Vice Chairman, Regional Partnership
• American-Israel Chamber of Commerce, Board of Directors
• Drake Beam & Morin (DBM), Executive Advisory Board
• Association for the Advancement of Medical Instrumentation (AAMI)

Jay S. Yadav, M.D., is the Founder and Chief Executive of CardioMEMS and a consulting cardiologist at the Piedmont Heart Institute. He was the founder of Angioguard (acquired by JNJ) and initial investor and director of SMART Therapeutics (acquired by Boston Scientific). Dr. Yadav is a director of several private medical device and technology companies. He is Co-Chair of the Metro Atlanta Bioscience Leadership Council, Chairman of the Medical Device Committee and a Director of Georgia Bio and The Indus Entrepreneurs. He is an active member of the American Heart Association and Chair of the Atlanta Heart Ball for 2013. Dr. Yadav has authored two books and over two hundred publications and has received numerous honors including the AHA Top Ten Scientific Advances for 2003, Ellis Island Medal of Honor for 2004, Southeast Medical Device Association Entrepreneur of the Year Award for 2010, Association of Telecom Professionals Award 2011 and Ernst and Young Entrepreneur of the Year for Healthcare (Southern Region) for 2011.

Mr. Hancock is President of Innovetica, LLC, helping small to mid-sized medical device companies with market analysis, strategic planning, new product development, and commercialization and market expansion strategies. Prior to founding Innovetica, Ashley managed the medical device portfolio for EndoChoice, an Atlanta-based venture-funded startup, and held senior marketing positions with C.R. Bard, where he was accountable for an extensive surgical implant portfolio. During his more than 21 years of professional experience, Mr. Hancock also held leadership positions with BP Amoco Chemical Company with oversight for manufacturing, operations planning, and supply chain optimization. He holds an MBA from the Kellogg School of Management at Northwestern University, and a Bachelor of Chemical Engineering from the Georgia Institute of Technology.

Robert Natowitz is the President of Ideal Search Services LLC. His focus is talent acquisition in the medical device field nationwide. He specializes in engineering recruitment, to include product development, R&D, design assurance and quality. Prior to relocating to Atlanta, he spent ten years as partner at DeMatteo Associates, a specialty search firm in Albany, NY.
Rob is a member of the American-Israel Chamber of Commerce. He is a volunteer at the Outreach and Advocacy Center which serves the homeless and near-homeless in downtown Atlanta. He received a BA in English from the State University of New York at Potsdam.

Charlie Harrison, President and CFO of Wynden Pharmaceuticals, Inc., brings 35 years of marketing and operating experience in driving new product and business commercialization in pharmaceutical, device and biotech markets.
Prior to founding Wynden, Charlie was founder and President of Critical Strategies, LLC, providing business development and strategic advisory support to life science companies. Prior to Critical Strategies, Charlie served in a series of senior management roles with Serologicals, Creative Product Resource, Unimed, SmithKline (now GSK) and Organon (now Schering). Charlie serves on the Boards of the American-Israel Chamber of Commerce, Southeast Region and Medical Compression Systems Ltd., a public Israel-based medical device company. Charlie received his BS in Mathematics from Pennsylvania State University and his MBA from the University of Massachusetts.

Ace has been involved in the electronics industry for the past thirty-five years, the past eight in medical devices. Currently he provides manufacturing, fabrication & design/engineering services to manufacturers. Prior to this he was the Director of Sales, Marketing, and Business Development at Sector Electronics and Sector Medical Corp. Sector Medical was a start-up medical device company that developed and marketed a screening device for Obstructive Sleep Apnea. During this time he also started a Home Health Agency providing in-home care for seniors.
Prior to working with Sector he spent sixteen years working for a fortune 200 company in electronic interconnection systems. He worked up through the sales ranks to the position of National Sales Manager and the Director of Global Marketing.
Ace holds a bachelors degree in Industrial Management from the Georgia Institute of Technology and his master’s degree in Business and Entrepreneurship from Wake Forest Babcock School of Management.

Mr. Crutchfield joined HMC in September 2008 and has more than 20 years of entrepreneurial and corporate experience in the healthcare industry, working with both startup, as well as large, international corporations.
Prior to joining Harbert Venture Partners, Mr. Crutchfield served as Senior Vice President/General Manager of the Pharmacy Services Division at US Oncology, a privately held, vertically integrated cancer care provider network with cancer clinics in more than 440 sites of service and a physician network consisting of over 1000 medical oncologists and radiation oncologists. His division was responsible for approximately $2 billion of annual revenue and under his leadership the division’s EBITDA grew to over $80 million.
Mr. Crutchfield was also a Senior Executive at CardinalHealth, where he served as Vice President of New Ventures. While there, he built and launched a new surgical products business unit, with revenues of over $75M and EBITDA of $20M through licensing of new technologies, acquisitions and creating a new North American sales channel.
In 1995, Mr. Crutchfield founded Surgical Innovations and Services, Inc. (SIS), a surgical laser management company. Under his leadership, SIS became a leader in the emerging outsource management sector, with over 300 hospitals and surgery centers under contract with SIS for management oversight and delivery of their surgical laser programs. In 2000, SIS merged with Surgical Laser Technologies, Inc. (SLTI) a publicly traded surgical laser-manufacturing firm. Mr. Crutchfield continued as President of SIS and served as VP of Sales, Marketing and Business Development for SLTI until he exited the company following its acquisition by publicly-traded Photomedex, Inc.,
Mr. Crutchfield has launched five successful new business ventures during his private and corporate career and has lead four merger and acquisition transactions. Mr. Crutchfield is a graduate of the University of Georgia and holds Bachelor of Science degrees in Political Science and Chemistry.
In addition to his responsibilities at Harbert, he is serving on the Governor’s Science and Technology Roadmap Steering Committee and Chairs the Commercialization Sub-Committee. He also is a member of the Alabama Obesity Institute Formation Steering Committee. He is an active member of the Birmingham Kiwanis Club, a member of the Board of Directors for the Birmingham Venture Club and Atlanta Venture Forum. He is married to Connie and they have three college-aged children.

Mr. Davis is a seasoned medical device executive with broad global and functional experience in finance, manufacturing, sales and general management.  He is currently the Founder & CEO of The MedCelerate Consulting Group (www.medcelerate.com).  MedCelerate enables medical device companies to grow and succeed in international markets at a faster velocity.  The practice focuses on early assessment of international opportunities through full manufacturing and commercial ramp-up activities.  Prior to founding MedCelerate, Mr. Davis was CEO of Tryton Medical, a ventured-backed, coronary stent, start-up company.  During his tenure at Tryton he raised $20 million in Series D financing and initiated enrollment in the company’s groundbreaking U.S. pivotal trial.  Mr. Davis also launched the company’s Side Branch Stent across Europe where it quickly became the established market leader.  Prior to joining Tryton, Mr. Davis was president of Guidant Japan with P&L responsibility for the company’s $225 million cardiovascular business.  Prior to his work in Japan, Mr. Davis managed Guidant’s product portfolio in 13 Asian countries. He was also instrumental in the start up and management of a FDA-regulated, Class III manufacturing facility in Dorado, Puerto Rico.  Mr. Davis started his career in various financial management roles with Cardiac Pacemakers Incorporated and Eli Lilly in the U.S. and Puerto Rico.  Mr. Davis holds a B.S. in mechanical engineering from the University of Minnesota and an M.B.A. from the University of Michigan.  Mr. Davis is the Chairman of the Board for ibiliti (www.ibiliti-nc.com), a non-profit organization created to accelerate the growth and commercialization of advanced medical technologies in North Carolina.

John Edwards is founder and CEO of Apeliotus Technologies, a medical device company that develops and commercializes products based on innovations from universities in the Southeast.
John has been involved in technology commercialization for more than 25 years at four successful university spin-off companies and a major university research lab.
John holds SB and SM degrees in physics from MIT and an MBA from the University of Chicago.

Paul Gianneschi is the Managing Principal and Founder of Hatch Medical, L.L.C., a privately held medical device incubator and technology brokerage firm focused on assisting physician inventors, entrepreneurs and early-stage companies with minimally invasive medical device technologies.
Paul has spent the past 18 years as an executive in the healthcare industry. Prior to founding Hatch Medical in 2000, Paul served over seven years in a series of senior level marketing and sales management positions with medical device industry leader, C. R. Bard, Inc.'s Peripheral Vascular Division. Prior to joining Bard, Paul worked in similar capacities with Bausch & Lomb and NDC Health / McKesson.
Paul earned a Bachelor of Science degree from the University of Florida and an M.B.A. in International Management from Mercer University, where he currently serves on the board of their business school.

Chris Lepore is the Senior Director of State Government Affairs for Johnson & Johnson (http://www.jnj.com), managing the Corporation’s state legislative and regulatory team in 10 Southern states, the District of Columbia, and Puerto Rico. Chris serves as Chair of Georgia Bio’s Government Affairs Committee, and Vice Chair of PhRMA’s Georgia Task Force. He joined Johnson & Johnson in 2004. He brings with him a strong government affairs background having 18 years of legislative and regulatory experience. Before joining Johnson & Johnson he was Manager of State Government Affairs for Schering-Plough Corporation, where he was responsible for the corporation's lobbying efforts in Arizona, Colorado, New Mexico, Utah, and Wyoming. Lepore is a graduate of the University of Northern Colorado where he received a Bachelor of Arts Degree in Communications. Johnson & Johnson, through its operating companies, is the world's most comprehensive and broadly based manufacturer of health care products.

Thomas Looby has served as Senior Vice President and Chief Marketing Officer since July 2010. Prior to that, from September 2006 until July 2010, he has served Given Imaging in various roles including the Vice President of Corporate Strategy and Planning and Director of Upper GI Products. Before joining Given Imaging, from January 2001 until September 2006, Mr. Looby worked for Eastman Kodak and Scitex Digital Printing as Director of Global Product Marketing and Business Strategy. Additionally, Mr. Looby has worked for Bayer, Chemineer and Giddings & Lewis in a variety of marketing and business management roles. Mr. Looby graduated with a B.S. in Chemical Engineering from the University of Notre Dame and holds an MBA from the University of Dayton.

Paul Murphy is currently the Vice President of Human Resources for the Medical Division of C. R. Bard, Inc. C. R. Bard, Inc. is a $2.6 billion manufacturer of disposable medical devices, and the Medical Division is the largest unit of Bard, with annual revenues of nearly $800 million. Mr. Murphy has been with Bard for 18 years in various key roles, including Chief HR officer for multiple Divisions as well as Bard’s operations in Europe. Prior to Bard Mr. Murphy worked for Solvay Pharmaceuticals and he was also a commissioned officer in the Medical Service Corps of the U.S. Army. Mr. Murphy has over 27 years of experience in the medical arena. He holds an undergraduate degree in Business from the University of Notre Dame, and an MBA from Kennesaw State University. Mr. Murphy serves on two additional non-profit Boards, as the Immediate Past Chairman of the Board for the Georgia Health Occupation Students of America Foundation, and the Vice-Chair of the Board of Directors of the Newton County Chamber of Commerce.

David Stern is currently the Sr. Vice President of Scientific Affairs and a member of the board of directors for CardioMEMS, Inc., an Atlanta based medical device company that has developed proprietary wireless sensing and communication technology designed to improve the management of chronic diseases.
David previously served as Vice President and Business Unit Manager of the Peripheral Technologies Division of C.R. Bard. He holds a B.S. in Biomedical Engineering from Rensselaer Polytechnic Institute and a M.E. in Biomedical Engineering from Worcester Polytechnic Institute. David served as SEMDA president for the 2008/2008 business year.